Trastuzumab

...with Genentech (a wholly-owned member of the Roche Group), sanofi-aventis, Biogen Idec and Biotest. The most advanced compound, trastuzumab-DM1 (T-DM1), is in Phase III testing being conducted by Genentech and Roche. Other ImmunoGen...

In this article: Multiple myeloma, ASH, Genentech, Cancer, American Society of Hematology, Non-Hodgkin's Lymphoma, and Monoclonal antibodies

It costs around GBP18,000 for a course of ten months' treatment It contrasts with the fast-tracking of the breast cancer drug Herceptin after pressure from patients and the intervention of the then Health Secretary Patricia...

In this article: Cancer, Bevacizumab, Europe, EU, Britain, Department of Health, and Breast cancer

...testing women with breast cancer who are candidates for drug treatments targeted to the HER-2 tumor receptor. The drugs are Herceptin® (trastuzumab) and lapatinib. His remarks were presented at a symposium sponsored by Abbott Molecular.

In this article: Breast cancer, Cancer, Amplification, Lapatinib, Medical advice, Journal of Clinical Oncology, 5-fluorouracil, and Cyclophosphamide

...clinics, drug treatments and publicity campaigns. In contrast to the rejection of sorafenib, when the anti-breast cancer drug Herceptin first came on the market, the then Health Secretary Patricia Hewitt declared that it would be...

In this article: Cancer, Europe, Department of Health, Breast cancer, Lung cancer, Britain, and Labour Party

In this article: Cancer, Breast cancer, Herceptin, Imperial College, London, Breakthrough Breast Cancer, and Patricia Hewitt

...needs. If a gene test shows that her tumor overproduces a substance called HER-2, she's considered to be a good candidate for the drug Herceptin, which cuts her chance of a recurrence nearly in half. If the test is negative, using the drug...

In this article: Antibiotic, Richard Powers, Autism, The Gold Bug Variations, Union of Concerned Scientists, United Kingdom, Washington, and California

...the scientists have not yet worked out why I go my particular form of breast cancer, HER2 positive, the type that needs Herceptin. They know it's an over expression of a human growth protein, but they don't know why it occurs. Apparently it's...

In this article: Cancer, Breast cancer, Obesity, Herceptin, UK, Fruit, HER2, and Tobacco

...led sales growth to go up in smoke. GlaxoSmithKline's ( GSK - news - people ) Tykerb breast cancer pill has hardly made a dent in Herceptin, the decade-old Roche ( RHHBY.PK - news - people ) medicine it was designed to compete with.

In this article: Pfizer, Merck, Zetia, Richard Clark, Eli Lilly, Bristol-Myers Squibb, Wyeth, GlaxoSmithKline, and Johnson & Johnson

...Pharmaceuticals, Surveys, Polls and Research, Women-related News Sales of HER2-Targeting Agents for Breast Cancer, Including Herceptin and Tykerb/Tyverb, Will Grow by 3.3 Percent Annually from 2008 to 2018 Incidence of Breast...

In this article: Breast cancer, Tykerb, HER2, Herceptin, Avastin, Trademark, Sanofi-Aventis, and AstraZeneca

...5:00 PST Standard adjuvant treatment for HER2-positive breast cancer patients, following primary surgery for their cancer, is Trastuzumab (Herceptin) - typically used in combination with chemotherapy. However, a new study by researchers at...

In this article: Breast cancer, Cancer, HER2, Dermatitis, Surgery, Fox Chase Cancer Center, and Fox Chase